Press Release: Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance

https://ift.tt/W95PNhe

 

from Sanofi - Aventis Groupe https://ift.tt/naRhDky
via IFTTT